Kyleena®: A member of the Bayer IUS family

A range of options for your patients3,5*

KYLEENA®

MIRENA®

  MIRENA® KYLEENA®
T-body size (mm)

32 X 32

Mirena Table

28 X 30

Kyleena table
Outer diameter of the insertion tube (mm)

4.4

3.8

Total LNG content (mg)

52

19.5

Maximum duration of use

5 years

5 years

Indication
  • Indicated for conception control for maximum up to 5 years
  • Indicated to treat idiopathic menorrhagia following appropriate diagnostic investigation in women accepting the contraceptive effect of Mirena®
  • Indicated for conception control for up to 5 years
Reversibility

Counsel your patient to request removal of her Bayer IUS
if she wishes to become pregnant.

Based on studies of each product, use of Bayer IUS products did not
alter the course of future fertility. Upon removal women return to their
normal level of fertility.3,5

Product Monograph amenorrhea rates at the end of Year 1

16%

12%

Estimated In vivo release rate of LNG (μg/24 hours)

15 (over 5 years)

9 (over 5 years)

* Data from separate Product Monographs; comparative clinical significance is unknown.

Start a conversation about Kyleena® and have your patients visit kyleena.ca for helpful resources

(for full access, enter the Drug Identification Number [DIN] 02459523 when requested).